AI-enabled virtual primary care
Doctronic
Doctronic is a direct-to-consumer 'AI doctor' offering free, anonymous AI consultations that produce assessments and action plans, with optional $39 video visits with licensed clinicians, prescriptions, and record retrieval for members. Its privacy notice is unusually detailed and patient-rights-forward, including no sale, no ad sharing, no training on chat data, and a right to request human review of AI clinical decisions, but its validation evidence is a vendor-authored preprint measuring agreement with clinicians, not independently verified outcomes.
Public-source research has been drafted; final human publication review and change-log detail are still required.
Summary judgment · 75% toward patient-directed
Potentially agency-expanding, with vendor-funnel and framing caveats
Patients choose Doctronic, can use it anonymously and free, and hold documented data rights, but the free AI consult also feeds a paid visit and prescription funnel, and the 'AI doctor' framing sits awkwardly beside its own not-a-doctor disclaimer.
Patient agency
How this tool changes agency
Action plans, visit preparation, a portable health record, referrals, prescriptions, and clinician escalation are directly action-oriented, including for uninsured users.
Users can request human physician review of any AI-generated clinical decision and the notice documents correction routes for record errors, but in-product correction of a live AI assessment is unverified.
Patient-facing signals
Who does this AI serve?
Patients choose and control the consultation, and the free tier asks nothing identifying, but the business model routes users toward paid visits, refills, and retention in Doctronic's own care ecosystem.
Can patients tell AI is involved?
The AI is the named product, every page carries an AI disclaimer, and the privacy notice has an explicit automated-decision-making section.
Can patients meaningfully choose?
Use is voluntary and free, anonymous no-account use is supported, identity verification and record imports are optional, and the notice separates required from optional data uses with revocation steps.
Can patients correct or challenge what the AI produces?
Users can request human physician review of any AI-generated clinical decision and the notice documents correction routes for record errors, but in-product correction of a live AI assessment is unverified.
Does it help patients understand or act?
Action plans, visit preparation, a portable health record, referrals, prescriptions, and clinician escalation are directly action-oriented, including for uninsured users.
Text findings
Who is left out or burdened?
Adults-only, English-centric evidence
Users must be 18+, the vendor's own study notes results reflect US English-language telehealth, $39 visits are low-cost but not free, and the strongest privacy protections accrue to users comfortable staying anonymous and account-free.
What happens to patient data?
Unusually detailed disclosure
The notice commits to no sale, no third-party ad sharing, no model training on chat data, AI inference inside Doctronic's private cloud, 7-year medical record retention, TEFCA access with CLEAR identity verification, immediate disconnection of anonymous sessions, and disclosed risks of SMS and email PHI channels.
Are the clinical boundaries clear?
Partial, mixed messaging
Footer disclaimers state Doctronic is not a doctor, does not practice medicine, and does not provide medical advice, while marketing calls it 'the #1 AI doctor' that generates diagnoses and treatment recommendations; human escalation exists but is optional and paid.
Who defined what good looks like?
Vendor-defined
The headline 99.2% treatment-plan concordance comes from a vendor-authored medRxiv preprint of 500 encounters that measures agreement with clinicians rather than correctness, acknowledges anchoring bias, and has no located peer-reviewed or independent replication.
Review method
Public-source review of the official website, detailed privacy and security notice, marketing and disclaimer language, blog claims, and the vendor's medRxiv benchmarking preprint; no hands-on testing, vendor interview, or independent or peer-reviewed validation located.
Draft profile · Medium draft, official sources plus vendor-authored preprint